Liv.72 Too Close to Liv.52: Calcutta HC Bars Shimla Drugs from Selling Product Imitating Himalaya Susmita Roy26 Dec 2025 9:41 PM ISTNew Delhi: The Calcutta High Court has passed an interim injunction in a trademark infringement and passing-off suit filed by Himalaya Global Holdings...
Abbott's Vildagliptin SR Secures CDSCO Panel Nod on Post-Marketing Safety Data Susmita Roy25 Dec 2025 7:32 PM ISTNew Delhi: Abbott Healthcare has received a positive regulatory outcome after presenting the Active Post-Marketing Surveillance (PMS) study report for...
Fortis Arm Challenges Rs 7 Cr GST Demand: Delhi HC to Decide Tax on Inpatient Medicines Susmita Roy24 Dec 2025 7:09 PM ISTThe tax authorities alleged that the hospital collected GST on medicines and consumables billed at MRP to patients but failed to deposit the same with...
State Drug Alert: 141 Medicine Samples Including Mankind's Telmisartan Fail CDSCO Quality Tests in November Susmita Roy23 Dec 2025 10:13 PM ISTNew Delhi: Reflecting continuing concerns over medicine quality in India's pharmaceutical supply chain, the Central Drugs Standard Control...
CDSCO Flags Popular Pantoprazole, Telmisartan Batches as Spurious in November Alert Susmita Roy22 Dec 2025 4:01 PM ISTNew Delhi: In a development that underscores growing concerns over counterfeit medicines in the supply chain, the Central Drugs Standard Control...
Calcutta High Court Quashes Blacklisting of Helax Healthcare Susmita Roy21 Dec 2025 5:30 PM ISTThe action was taken in connection with the supply of Telmisartan Tablet IP 40 mg under a state government tender.
CDSCO Alert: 64 Drug Batches Including Metformin, Paracetamol Declared Not of Standard Quality in November Susmita Roy20 Dec 2025 6:36 PM ISTNew Delhi: In a strong reminder of persistent quality concerns in India's pharmaceutical supply chain, 64 batches of drugs and medical products have...
Aurobindo Pharma Gets HC Relief in Compensation Cess Refund Dispute, GST Orders Quashed Susmita Roy19 Dec 2025 3:15 PM ISTNew Delhi: In a major relief to Aurobindo Pharma regarding the refund of compensation cess paid on coal used to manufacture medicines for export, the...
DCGI Moves to Enforce 2009 Ban on Single-Drug Artemisinin Pills Amid Resistance Concerns: Report Parthika Patel18 Dec 2025 3:02 PM ISTNew Delhi: In a renewed push to safeguard India's malaria treatment protocols, the Drugs Controller General of India (DCGI) has directed all State and...
Health Ministry Proposes Perpetual Validity for Medical Device Licences Susmita Roy17 Dec 2025 1:15 PM ISTNew Delhi: Through a recent Gazette notification, the Ministry of Health and Family Welfare (Department of Health and Family Welfare) has issued a...
Diabetes Drug Bladder Cancer Risk Debate: Madras HC Orders Expert Review on Pioglitazone, Sitagliptin Safety Susmita Roy16 Dec 2025 3:30 PM ISTNew Delhi: The Madras High Court has directed the Union Ministry of Health and Family Welfare to constitute a team of medical experts to examine the...
CDSCO Panel Seeks Revised Phase IV Study for Zydus' Empagliflozin, Metformin FDC Susmita Roy15 Dec 2025 1:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO), has asked Zydus Healthcare...
